Natural history, response to systemic therapy, and genomic landscape of plasmacytoid urothelial carcinoma

BACKGROUND: Plasmacytoid urothelial carcinoma (PUC) is a rare, aggressive histologic variant of urothelial cancer characterised by a diffuse growth pattern and CDH1 mutation. We studied the efficacy of preoperative platinum-based chemotherapy in nonmetastatic PUC and immune checkpoint inhibitors (IC...

Descripción completa

Detalles Bibliográficos
Autores principales: Teo, Min Yuen, Al-Ahmadie, Hikmat, Seier, Kenneth, Tully, Christopher, Regazzi, Ashley M., Pietzak, Eugene, Solit, David B., Tickoo, Satish, Reuter, Victor, Cha, Eugene K., Herr, Harry, Donahue, Timothy, Donat, Sherri M., Dalbagni, Guido, Bochner, Bernard H., Funt, Samuel, Iyer, Gopakumar V., Bajorin, Dean F., Ostrovnaya, Irina, Rosenberg, Jonathan E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8007750/
https://www.ncbi.nlm.nih.gov/pubmed/33473164
http://dx.doi.org/10.1038/s41416-020-01244-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8007750/
https://www.ncbi.nlm.nih.gov/pubmed/33473164
http://dx.doi.org/10.1038/s41416-020-01244-2

Ejemplares similares